| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.68B | 25.93B | 23.32B | 21.56B | 18.41B | 16.16B |
| Gross Profit | 6.21B | 6.03B | 5.36B | 4.82B | 4.12B | 3.47B |
| EBITDA | 3.34B | 3.20B | 2.88B | 2.66B | 2.20B | 1.68B |
| Net Income | 2.28B | 2.19B | 1.97B | 1.60B | 1.49B | 1.09B |
Balance Sheet | ||||||
| Total Assets | 16.02B | 17.53B | 16.15B | 14.18B | 12.88B | 11.20B |
| Cash, Cash Equivalents and Short-Term Investments | 7.08B | 8.20B | 8.33B | 7.37B | 6.35B | 5.84B |
| Total Debt | 1.36B | 1.30B | 1.44B | 1.40B | 1.40B | 1.43B |
| Total Liabilities | 4.74B | 5.70B | 5.63B | 5.05B | 4.75B | 4.05B |
| Stockholders Equity | 11.26B | 11.81B | 10.51B | 9.12B | 8.12B | 7.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 971.47M | 1.59B | 1.59B | 1.28B | 1.01B |
| Operating Cash Flow | 0.00 | 2.06B | 2.46B | 1.80B | 1.29B | 1.09B |
| Investing Cash Flow | 0.00 | -1.14B | -926.71M | -273.30M | -254.65M | -144.11M |
| Financing Cash Flow | 0.00 | -1.04B | -546.50M | -501.65M | -526.75M | -466.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥29.32B | 12.67 | ― | 2.93% | 11.53% | 23.23% | |
72 Outperform | ¥50.64B | 23.84 | ― | 1.50% | 13.48% | 35.63% | |
68 Neutral | ¥31.92B | 20.63 | ― | 4.58% | 4.58% | -15.00% | |
63 Neutral | ¥5.20B | 9.17 | ― | 2.28% | ― | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
47 Neutral | ¥4.49B | -18.61 | ― | ― | -40.57% | 83.14% |